Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China · Delayed Price · Currency is CNY 39.23
+0.08 (0.20%)
Sep 10, 2026, 2:09 PM CST
SHA:688091 Revenue
Shanghai Yizhong Pharmaceutical had revenue of 86.68M CNY in the quarter ending June 30, 2026, a decrease of -2.91%. This brings the company's revenue in the last twelve months to 321.61M, up 51.76% year-over-year. In the year 2025, Shanghai Yizhong Pharmaceutical had annual revenue of 316.08M with 82.14% growth.
Revenue (ttm)
321.61M
Revenue Growth
+51.76%
P/S Ratio
24.93
Revenue / Employee
735.94K
Employees
437
Market Cap
8.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 316.08M | 142.54M | 82.14% |
| Dec 31, 2024 | 173.53M | -186.72M | -51.83% |
| Dec 31, 2023 | 360.25M | 124.30M | 52.68% |
| Dec 31, 2022 | 235.96M | 231.88M | 5,686.75% |
| Dec 31, 2021 | 4.08M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.